Regulatory Sciences
-
Mandatory HTAR Implementation In The EU: Part 2
9/17/2024
Here, we provide guidance on how to prepare for the new HTAR requirements and ensure successful compliance for your product launch.
-
Mandatory EU HTAR Implementation: Part 1
9/17/2024
Discover how to prepare for the EU Health Technology Assessment Regulation (HTAR), effective January 2025, to ensure a successful product launch.
-
How To Successfully Prepare For The HTAR Implementation In The EU
9/17/2024
The European Health Technology Assessment Regulation (HTAR) will significantly impact the market access process in Europe. See how HTDs can prepare for the upcoming joint clinical assessments.
-
MLR Submission Content: Setting Yourself Up For A Successful PRC Review
9/17/2024
A well-prepared MLR submission is crucial for efficient PRC reviews. It ensures timely and effective review processes and reduces unnecessary delays.
-
Highlights From FDA's Analytical Test Method Validation Guidance
9/17/2024
The FDA has updated its guidance on analytical test method validation, aligning with ICH Q2(R2). Review key changes including streamlined requirements, focus on critical parameters, and flexibility.
-
FDA Animal Rule: Overview And Impact On Drug Development
9/17/2024
Streamline drug approvals using the Animal Rule, which allows for well-controlled animal studies when human trials aren't possible. Learn more about this expedited pathway.
-
The Moving Regulatory Landscape For Gene Therapy Trials In EU: Part 1
9/17/2024
The Clinical Trial Regulation (CTR) harmonizes clinical trial applications (CTAs) in the EU, but doesn't cover GMO applications for gene therapy studies.
-
The Moving Regulatory Landscape For Gene Therapy Trials In EU: Part 2
9/17/2024
The SNIF form, a crucial part of GMO applications for clinical trials with GTMPs, now requires separate submission through the ESFC platform.
-
Advertising & Promotional Review Consulting
8/29/2024
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
European Regulatory Development
8/29/2024
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.